Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung

Benjamin Philip Levy; Luis G. Paz-Ares; Jaafar Bennouna; Enriqueta Felip; Delvys Rodriguez Abreu; Dolores Isla; Fabrice Barlesi; Olivier Molinier; Jeannick Madelaine; Clarisse Audigier-Valette; Sang-We Kim; Mustafa Ozguroglu; Mustafa Erman; Firas Benyamine Badin; Tarek Mekhail; Ronald J. Scheff; Jonathan W. Riess

doi:10.1200/JCO.2018.36.15_suppl.TPS9117

Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung

Benjamin Philip Levy
, Luis G. Paz-Ares
, Jaafar Bennouna
, Enriqueta Felip
, Delvys Rodriguez Abreu
, Dolores Isla
, Fabrice Barlesi
, Olivier Molinier
, Jeannick Madelaine
, Clarisse Audigier-Valette
, Sang-We Kim
, Mustafa Ozguroglu
, Mustafa Erman
, Firas Benyamine Badin
, Tarek Mekhail
, Ronald J. Scheff
, Jonathan W. Riess

Division of Preventive Oncology (Interdisciplinary)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	36
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2018.36.15_suppl.TPS9117
Publication status	Published - 20 May 2018

Access to Document

10.1200/JCO.2018.36.15_suppl.TPS9117

Cite this

Levy, B. P., Paz-Ares, L. G., Bennouna, J., Felip, E., Abreu, D. R., Isla, D., Barlesi, F., Molinier, O., Madelaine, J., Audigier-Valette, C., Kim, S.-W., Ozguroglu, M., Erman, M., Badin, F. B., Mekhail, T., Scheff, R. J., & Riess, J. W. (2018). Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung. Journal of Clinical Oncology, 36(15). https://doi.org/10.1200/JCO.2018.36.15_suppl.TPS9117

@article{86c2ab3209bb40f5842ef1b60d551498,

title = "Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung",

author = "Levy, \{Benjamin Philip\} and Paz-Ares, \{Luis G.\} and Jaafar Bennouna and Enriqueta Felip and Abreu, \{Delvys Rodriguez\} and Dolores Isla and Fabrice Barlesi and Olivier Molinier and Jeannick Madelaine and Clarisse Audigier-Valette and Sang-We Kim and Mustafa Ozguroglu and Mustafa Erman and Badin, \{Firas Benyamine\} and Tarek Mekhail and Scheff, \{Ronald J.\} and Riess, \{Jonathan W.\}",

year = "2018",

month = may,

day = "20",

doi = "10.1200/JCO.2018.36.15\_suppl.TPS9117",

language = "English",

volume = "36",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "15",

}

Levy, BP, Paz-Ares, LG, Bennouna, J, Felip, E, Abreu, DR, Isla, D, Barlesi, F, Molinier, O, Madelaine, J, Audigier-Valette, C, Kim, S-W, Ozguroglu, M, Erman, M, Badin, FB, Mekhail, T, Scheff, RJ & Riess, JW 2018, 'Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung', Journal of Clinical Oncology, vol. 36, no. 15. https://doi.org/10.1200/JCO.2018.36.15_suppl.TPS9117

TY - JOUR

T1 - Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung

AU - Levy, Benjamin Philip

AU - Paz-Ares, Luis G.

AU - Bennouna, Jaafar

AU - Felip, Enriqueta

AU - Abreu, Delvys Rodriguez

AU - Isla, Dolores

AU - Barlesi, Fabrice

AU - Molinier, Olivier

AU - Madelaine, Jeannick

AU - Audigier-Valette, Clarisse

AU - Kim, Sang-We

AU - Ozguroglu, Mustafa

AU - Erman, Mustafa

AU - Badin, Firas Benyamine

AU - Mekhail, Tarek

AU - Scheff, Ronald J.

AU - Riess, Jonathan W.

PY - 2018/5/20

Y1 - 2018/5/20

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000442916008021&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1200/JCO.2018.36.15_suppl.TPS9117

DO - 10.1200/JCO.2018.36.15_suppl.TPS9117

M3 - Meeting Abstract

SN - 0732-183X

VL - 36

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -

Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung

Access to Document

Other files and links

Cite this